{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:57:52Z","timestamp":1779119872177,"version":"3.51.4"},"reference-count":73,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Multidrug resistance (MDR) is a key challenge in clinical chemotherapy.\nThe combination of drugs can effectively reverse multi-drug resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>In this study, doxorubicin (DOX) was capsulated into nanoparticles formed by an amphiphilic\nPEGylated-poly (\u03b1-lipoic acid)-methanamide analogue of celastrol (mPEG-P\u03b1LA-CEN)\nprodrug polymer. CEN was linked to the branched chain of poly (\u03b1-lipoic acid) by forming ester\nbonds. DOX was physically trapped inside the nanoparticles via electrostatic interaction. Both\ndrugs can be simultaneously released in response to low pH and high GSH in order to overcome\nDOX resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The chemical structure of the mPEG-P\u03b1LA-CEN-DOX NPs was confirmed through 1H\nNMR, FT-IR spectroscopy, UV-Vis spectrum, DLS, and TEM. Drug-loading content, efficacy,\nand drug release were measured using HPLC. Cell toxicity was examined using an MTT assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CEN\/DOX-loaded nanoparticles were found to have spherical shapes with diameters of\naround 229.7 nm. The NPs exhibited high biocompatibility and released 92% DOX and 71.8%\nCEN in response to low pH and high GSH of tumor microenvironments. As dual drug-loaded\nnanoparticles, the efficacy of mPEG-P\u03b1LA-CEN-DOX NPs against tumor cell lines in vitro was\nenhanced for both MCF-7 and MCF-7\/ADR compared to free DOX. Compared to free DOX, the\nIC50 of mPEG-P\u03b1LA-CEN-DOX NPs reduced from 46.10 \u03bcM to 8.36 \u03bcM for the MCF-7\/ADR\ncell line.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In conclusion, this study demonstrated that PEGylated poly (\u03b1-lipoic acid)-CEN\ncopolymers can be used not only as biocompatible, stimulation-responsive anticancer drug nanocarriers\nbut also as chemosensitizers to overcome multidrug resistance, which provide a theoretical\nbase for clinical application of CEN\/DOX nanodrug.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115672018298512240819101159","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T02:13:56Z","timestamp":1724811236000},"page":"88-100","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Celastrol Derivative\/DOX Co-Assembled Nanodrug for Enhanced Antitumor Therapy"],"prefix":"10.2174","volume":"23","author":[{"given":"Jiangtao","family":"Su","sequence":"first","affiliation":[{"name":"School of Biological Engineering and Food Science, Hubei University of Technology, Wuhan,430068, China"},{"name":"National \u2018111\u2019 Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan, 430068, China"},{"name":"Key Laboratory of Industrial Microbiology in Hubei, Hubei University of Technology, Wuhan,430068, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Biological Engineering and Food Science, Hubei University of Technology, Wuhan,430068, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Biological Engineering and Food Science, Hubei University of Technology, Wuhan,430068, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuchu","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Biological Engineering and Food Science, Hubei University of Technology, Wuhan,430068, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Biological Engineering and Food Science, Hubei University of Technology, Wuhan,430068, China"},{"name":"Key Laboratory of Industrial Microbiology in Hubei, Hubei University of Technology, Wuhan,430068, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Humanwell Healthcare (Group) Co., Ltd, Wuhan,430010, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Biological Engineering and Food Science, Hubei University of Technology, Wuhan,430068, China"},{"name":"National \u2018111\u2019 Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan, 430068, China"},{"name":"Hubei Province Cooperative Innovation Center for Industrial Fermentation, Hubei University of Technology, Wuhan, 430068, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1158\/1078-0432.CCR-14-1213","volume":"21","author":"Pribluda A.","year":"2015","unstructured":"Pribluda A.; de la Cruz C.C.; Jackson E.L.; Intratumoral heterogeneity: From diversity comes resistance. Clin Cancer Res  2015,21(13),2916-2923","journal-title":"Clin Cancer Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","volume":"22","author":"Ambudkar S.V.","year":"2003","unstructured":"Ambudkar S.V.; Kimchi-Sarfaty C.; Sauna Z.E.; Gottesman M.M.; P-glycoprotein: from genomics to mechanism. Oncogene  2003,22(47),7468-7485","journal-title":"Oncogene"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"111108","DOI":"10.1016\/j.biopha.2020.111108","volume":"134","author":"Mao J.","year":"2021","unstructured":"Mao J.; Qiu L.; Ge L.; Zhou J.; Ji Q.; Yang Y.; Long M.; Wang D.; Teng L.; Chen J.; Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer. Biomed Pharmacother  2021,134(7),111108","journal-title":"Biomed Pharmacother"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biotechadv.2013.11.009","volume":"32","author":"Liu J.","year":"2014","unstructured":"Liu J.; Huang Y.; Kumar A.; Tan A.; Jin S.; Mozhi A.; Liang X.J.; pH-Sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv  2014,32(4),693-710","journal-title":"Biotechnol Adv"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"14820","DOI":"10.1021\/jacs.6b06243","volume":"138","author":"Fach M.","year":"2016","unstructured":"Fach M.; Radi L.; Wich P.R.; Nanoparticle assembly of surface-modified proteins. J Am Chem Soc  2016,138(45),14820-14823","journal-title":"J Am Chem Soc"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s11434-016-1182-z","volume":"61","author":"Qureshi W.A.","year":"2016","unstructured":"Qureshi W.A.; Zhao R.; Wang H.; Ji T.; Ding Y.; Ihsan A.; Mujeeb A.; Nie G.; Zhao Y.; Co-delivery of doxorubicin and quercetin via mPEG\u2013PLGA copolymer assembly for synergistic anti-tumor efficacy and reducing cardio-toxicity. Sci Bull  2016,61(21),1689-1698","journal-title":"Sci Bull"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/adma.201104763","volume":"24","author":"Tang F.","year":"2012","unstructured":"Tang F.; Li L.; Chen D.; Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater  2012,24(12),1504-1534","journal-title":"Adv Mater"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s11434-015-0840-x","volume":"60","author":"Lin B.","year":"2015","unstructured":"Lin B.; Su H.; Jin R.; Li D.; Wu C.; Jiang X.; Xia C.; Gong Q.; Song B.; Ai H.; Multifunctional dextran micelles as drug delivery carriers and magnetic resonance imaging probes. Sci Bull (Beijing)  2015,60(14),1272-1280","journal-title":"Sci Bull (Beijing)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1021\/acs.nanolett.6b00664","volume":"16","author":"Frangville C.","year":"2016","unstructured":"Frangville C.; Li Y.; Billotey C.; Talham D.R.; Taleb J.; Roux P.; Marty J.D.; Mingotaud C.; Assembly of double-hydrophilic block copolymers triggered by gadolinium ions: New colloidal mri contrast agents. Nano Lett  2016,16(7),4069-4073","journal-title":"Nano Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"10790","DOI":"10.1039\/C4NR07450E","volume":"7","author":"Zhang H.","year":"2015","unstructured":"Zhang H.; Hu H.; Zhang H.; Dai W.; Wang X.; Wang X.; Zhang Q.; Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis. Nanoscale  2015,7(24),10790-10800","journal-title":"Nanoscale"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1021\/acsami.5b11308","volume":"8","author":"Zhou H.","year":"2016","unstructured":"Zhou H.; Hou X.; Liu Y.; Zhao T.; Shang Q.; Tang J.; Liu J.; Wang Y.; Wu Q.; Luo Z.; Wang H.; Chen C.; Superstable magnetic nanoparticles in conjugation with near-infrared dye as a multimodal theranostic platform. ACS Appl Mater Interfaces  2016,8(7),4424-4433","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biomaterials.2016.11.009","volume":"114","author":"Ergen C.","year":"2017","unstructured":"Ergen C.; Heymann F.; Al Rawashdeh W.; Gremse F.; Bartneck M.; Panzer U.; Pola R.; Pechar M.; Storm G.; Mohr N.; Barz M.; Zentel R.; Kiessling F.; Trautwein C.; Lammers T.; Tacke F.; Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles. Biomaterials  2017,114,106-120","journal-title":"Biomaterials"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1002\/smll.201601741","volume":"12","author":"Oishi M","year":"2016","unstructured":"Oishi M; Sugiyama S.; An efficient particle-based DNA circuit system: Catalytic disassembly of DNA\/peg-modified gold nanoparticle-magnetic bead composites for colorimetric detection of mirna. Small  2016,12(37),5153-5158","journal-title":"Small"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1080\/10717544.2020.1831106","volume":"27","author":"He B.","year":"2020","unstructured":"He B.; Sui X.; Yu B.; Wang S.; Shen Y.; Cong H.; Recent advances in drug delivery systems for enhancing drug penetration into tumors. Drug Deliv  2020,27(1),1474-1490","journal-title":"Drug Deliv"},{"key":"ref=15","first-page":"409","volume":"71","author":"Maeda H.","year":"2009","unstructured":"Maeda H.; Bharate G.Y.; Daruwalla J.; Polymeric drugs for efficient tumor-targeted drug delivery based on epr-effect.  2009,71(3),409-419"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","volume":"63","author":"Torchilin V.","year":"2011","unstructured":"Torchilin V.; Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev  2011,63(3),131-135","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"Cabral H.","year":"2011","unstructured":"Cabral H.; Matsumoto Y.; Mizuno K.; Chen Q.; Murakami M.; Kimura M.; Terada Y.; Kano M.R.; Miyazono K.; Uesaka M.; Nishiyama N.; Kataoka K.; Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol  2011,6(12),815-823","journal-title":"Nat Nanotechnol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.nantod.2015.09.005","volume":"10","author":"Cheng R.","year":"2015","unstructured":"Cheng R.; Meng F.; Deng C.; Zhong Z.; Bioresponsive polymeric nanotherapeutics for targeted cancer chemotherapy. Nano Today  2015,10(5),656-670","journal-title":"Nano Today"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.biomaterials.2013.01.084","volume":"34","author":"Cheng R.","year":"2013","unstructured":"Cheng R.; Meng F.; Deng C.; Zhong Z.; Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials  2013,34(14),3647-3657","journal-title":"Biomaterials"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1021\/am303073u","volume":"5","author":"Li M.","year":"2013","unstructured":"Li M.; Song W.; Tang Z.; Lv S.; Lin L.; Sun H.; Li Q.; Yang Y.; Hong H.; Chen X.; Nanoscaled poly(L-glutamic acid)\/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer. ACS Appl Mater Interfaces  2013,5(5),1781-1792","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"17560","DOI":"10.1021\/ja207150n","volume":"133","author":"Du J.Z.","year":"2011","unstructured":"Du J.Z.; Du X.J.; Mao C.Q.; Wang J.; Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc  2011,133(44),17560-17563","journal-title":"J Am Chem Soc"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1002\/anie.200907210","volume":"49","author":"Du J.Z.","year":"2010","unstructured":"Du J.Z.; Sun T.M.; Song W.J.; Wu J.; Wang J.; A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew Chem Int Ed  2010,49(21),3621-3626","journal-title":"Angew Chem Int Ed"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1039\/C7BM01025G","volume":"6","author":"Liu J.","year":"2018","unstructured":"Liu J.; Iqbal S.; Du X.J.; Yuan Y.; Yang X.; Li H.J.; Wang J.; Ultrafast charge-conversional nanocarrier for tumor-acidity-activated targeted drug elivery. Biomater Sci  2018,6(2),350-355","journal-title":"Biomater Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"7373","DOI":"10.1021\/jacs.7b12025","volume":"140","author":"Chen D.","year":"2018","unstructured":"Chen D.; Zhang G.; Li R.; Guan M.; Wang X.; Zou T.; Zhang Y.; Wang C.; Shu C.; Hong H.; Wan L.J.; Biodegradable, hydrogen peroxide, and glutathione dual responsive nanoparticles for potential programmable paclitaxel release. J Am Chem Soc  2018,140(24),7373-7376","journal-title":"J Am Chem Soc"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1039\/C7BM00793K","volume":"6","author":"Yuan F.","year":"2018","unstructured":"Yuan F.; Li J.L.; Cheng H.; Zeng X.; Zhang X.Z.; A redox-responsive mesoporous silica based nanoplatform for in vitro tumor-specific fluorescence imaging and enhanced photodynamic therapy. Biomater Sci  2018,6(1),96-100","journal-title":"Biomater Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s40843-018-9277-8","volume":"61","author":"Chen K.","year":"2018","unstructured":"Chen K.; Liao S.; Guo S.; Zhang H.; Cai H.; Gong Q.; Gu Z.; Luo K.; Enzyme\/pH-sensitive dendritic polymer-DOX conjugate for cancer treatment. Sci China Mater  2018,61(11),1462-1474","journal-title":"Sci China Mater"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/med.21485","volume":"38","author":"Zhang P.","year":"2018","unstructured":"Zhang P.; Wu J.; Xiao F.; Zhao D.; Luan Y.; Disulfide bond based polymeric drug carriers for cancer chemotherapy and relevant redox environments in mammals. Med Res Rev  2018,38(5),1485-1510","journal-title":"Med Res Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.1039\/D0PY00987C","volume":"11","author":"Kuang G.","year":"2020","unstructured":"Kuang G.; Zhang Q.; He S.; Wu Y.; Huang Y.; Reduction-responsive disulfide linkage core-cross-linked polymeric micelles for site-specific drug delivery. Polym Chem  2020,11(44),7078-7086","journal-title":"Polym Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1002\/anie.201411615","volume":"54","author":"Mizuhara T.","year":"2015","unstructured":"Mizuhara T.; Saha K.; Moyano D.F.; Kim C.S.; Yan B.; Kim Y.K.; Rotello V.M.; Acylsulfonamide-functionalized zwitterionic gold nanoparticles for enhanced cellular uptake at tumor ph. Angew Chem Int Ed  2015,54(22),6567-6570","journal-title":"Angew Chem Int Ed"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1039\/D0BM90037K","volume":"8","author":"Liu Z.","year":"2020","unstructured":"Liu Z.; Shen N.; Tang Z.; Zhang D.; Ma L.; Yang C.; Chen X.; Correction: An eximious and affordable GSH stimulus-responsive poly(\u03b1-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy. Biomater Sci  2020,8(10),2977-2977","journal-title":"Biomater Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1002\/adma.201502486","volume":"27","author":"Song J.","year":"2015","unstructured":"Song J.; Yang X.; Jacobson O.; Huang P.; Sun X.; Lin L.; Yan X.; Niu G.; Ma Q.; Chen X.; Ultrasmall gold nanorod vesicles with enhanced tumor accumulation and fast excretion from the body for cancer therapy. Adv Mater  2015,27(33),4910-4917","journal-title":"Adv Mater"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"113971","DOI":"10.1016\/j.addr.2021.113971","volume":"178","author":"Bentley E.R.","year":"2021","unstructured":"Bentley E.R.; Little S.R.; Local delivery strategies to restore immune homeostasis in the context of inflammation. Adv Drug Deliv Rev  2021,178,113971","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.addr.2018.12.011","volume":"148","author":"Song Y.H.","year":"2019","unstructured":"Song Y.H.; Agrawal N.K.; Griffin J.M.; Schmidt C.E.; Recent advances in nanotherapeutic strategies for spinal cord injury repair. Adv Drug Deliv Rev  2019,148,38-59","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jconrel.2020.09.008","volume":"327","author":"Dou Y.","year":"2020","unstructured":"Dou Y.; Li C.; Li L.; Guo J.; Zhang J.; Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release  2020,327,641-666","journal-title":"J Control Release"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1039\/C3NR04804G","volume":"6","author":"Chen C.K.","year":"2014","unstructured":"Chen C.K.; Law W.C.; Aalinkeel R.; Yu Y.; Nair B.; Wu J.; Mahajan S.; Reynolds J.L.; Li Y.; Lai C.K.; Tzanakakis E.S.; Schwartz S.A.; Prasad P.N.; Cheng C.; Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug\u2013gene co-delivery to cancer cells. Nanoscale  2014,6(3),1567-1572","journal-title":"Nanoscale"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.drup.2021.100743","volume":"54","author":"Wang J.Q.","year":"2021","unstructured":"Wang J.Q.; Yang Y.; Cai C.Y.; Teng Q.X.; Cui Q.; Lin J.; Assaraf Y.G.; Chen Z.S.; Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance. Drug Resist Updat  2021,54,100743","journal-title":"Drug Resist Updat"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.2174\/0929867329666220209103538","volume":"29","author":"Santi M.D.","year":"2022","unstructured":"Santi M.D.; Ortega M.G.; Peralta M.A.; Daniela. Santi M, Gabriela. Ortega M, and Peralta M A. A state-of-the-art review and prospective therapeutic applications of prenyl flavonoids as chemosensitizers against antifungal multidrug resistance in candida albicans. Curr Med Chem  2022,29(24),4251-4281","journal-title":"Curr Med Chem"},{"key":"ref=38","first-page":"88","volume":"2018","author":"Beheshti M.","year":"2018","unstructured":"Beheshti M.; Different strategies to overcome multidrug resistance in cancer research review. Biotechnol Adv  2018,2018,88-89","journal-title":"Biotechnol Adv"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4155\/fmc-2019-0285","volume":"12","author":"Lin H.","year":"2020","unstructured":"Lin H.; Qiao Y.; Yang H.; Nan Q.; Qu W.; Feng F.; Liu W.; Chen Y.; Sun H.; Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy. Future Med Chem  2020,12(3),243-267","journal-title":"Future Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1158\/1541-7786.MCR-09-0243","volume":"7","author":"Chen M.","year":"2009","unstructured":"Chen M.; Rose A.E.; Doudican N.; Osman I.; Orlow S.J.; Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Mol Cancer Res  2009,7(12),1946-1953","journal-title":"Mol Cancer Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"12639","DOI":"10.1039\/C8NR02700E","volume":"10","author":"Xiao Y.","year":"2018","unstructured":"Xiao Y.; Liu J.; Guo M.; Zhou H.; Jin J.; Liu J.; Liu Y.; Zhang Z.; Chen C.; Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance. Nanoscale  2018,10(26),12639-12649","journal-title":"Nanoscale"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/CAD.0000000000000647","volume":"29","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Liu Q.; Chen H.; You J.; Peng B.; Cao F.; Zhang X.; Chen Q.; Uzan G.; Xu L.; Zhang D.; Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs  2018,29(8),748-755","journal-title":"Anticancer Drugs"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2010.10.025","volume":"303","author":"Kannaiyan R.","year":"2011","unstructured":"Kannaiyan R.; Shanmugam M.K.; Sethi G.; Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer. Cancer Lett  2011,303(1),9-20","journal-title":"Cancer Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-05-4529","volume":"66","author":"Yang H.","year":"2006","unstructured":"Yang H.; Chen D.; Cui Q.C.; Yuan X.; Dou Q.P.; Celastrol, a triterpene extracted from the Chinese \u201cThunder of God Vine,\u201d is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res  2006,66(9),4758-4765","journal-title":"Cancer Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.canlet.2010.07.015","volume":"332","author":"Li-Weber M.","year":"2013","unstructured":"Li-Weber M.; Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett  2013,332(2),304-312","journal-title":"Cancer Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbrc.2010.03.050","volume":"394","author":"Salminen A.","year":"2010","unstructured":"Salminen A.; Lehtonen M.; Paimela T.; Kaarniranta K.; Celastrol: Molecular targets of thunder god vine. Biochem Biophys Res Commun  2010,394(3),439-442","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/CAD.0000000000000621","volume":"29","author":"Bufu T.","year":"2018","unstructured":"Bufu T.; Di X.; Yilin Z.; Gege L.; Xi C.; Ling W.; Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K\/AKT signaling pathway. Anticancer Drugs  2018,29(6),530-538","journal-title":"Anticancer Drugs"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biopha.2015.01.007","volume":"70","author":"Nabekura T.","year":"2015","unstructured":"Nabekura T.; Hiroi T.; Kawasaki T.; Uwai Y.; Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. Biomed Pharmacother  2015,70,140-145","journal-title":"Biomed Pharmacother"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biomaterials.2017.07.036","volume":"154","author":"Tan Y.","year":"2018","unstructured":"Tan Y.; Zhu Y.; Zhao Y.; Wen L.; Meng T.; Liu X.; Yang X.; Dai S.; Yuan H H.; Hu F.; Mitochondrial alkaline ph-responsive drug release mediated by celastrol loaded glycolipid-like micelles for cancer therapy. Biomaterials  2018,154,169-181","journal-title":"Biomaterials"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.actbio.2016.05.012","volume":"39","author":"Choi J.Y.","year":"2016","unstructured":"Choi J.Y.; Ramasamy T.; Kim S.Y.; Kim J.; Ku S.K.; Youn Y.S.; Kim J.R.; Jeong J.H.; Choi H.G.; Yong C.S.; Kim J.O.; PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy. Acta Biomater  2016,39,94-105","journal-title":"Acta Biomater"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","volume":"8","author":"Guo L.","year":"2017","unstructured":"Guo L.; Luo S.; Du Z.; Zhou M.; Li P.; Fu Y.; Sun X.; Huang Y.; Zhang Z.; Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis. Nat Commun  2017,8(1),878-879","journal-title":"Nat Commun"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1074\/jbc.M600072200","volume":"281","author":"Sun H.","year":"2006","unstructured":"Sun H.; Liu X.; Xiong Q.; Shikano S.; Li M.; Chronic inhibition of cardiac Kir2.1 and HERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking. J Biol Chem  2006,281(9),5877-5884","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e35733","DOI":"10.1371\/journal.pone.0035733","volume":"7","author":"Kusy S.","year":"2012","unstructured":"Kusy S.; Ghosn E.E.B.; Herzenberg L.A.; Contag C.H.; Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice. PLoS One  2012,7(4),e35733","journal-title":"PLoS One"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/14756366.2017.1404590","volume":"33","author":"Zhang H.J.","year":"2018","unstructured":"Zhang H.J.; Zhang G.R.; Piao H.R.; Quan Z.S.; Synthesis and characterisation of celastrol derivatives as potential anticancer agents. J Enzyme Inhib Med Chem  2018,33(1),190-198","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1021\/acs.jnatprod.0c00067","volume":"83","author":"He Q.W.","year":"2020","unstructured":"He Q.W.; Feng J.H.; Hu X.L.; Long H.; Huang X.F.; Jiang Z.Z.; Zhang X.Q.; Ye W.C.; Wang H.; Synthesis and biological evaluation of celastrol derivatives as potential immunosuppressive agents. J Nat Prod  2020,83(9),2578-2586","journal-title":"J Nat Prod"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2217\/nnm.11.19","volume":"6","author":"Jokerst J.V.","year":"2011","unstructured":"Jokerst J.V.; Lobovkina T.; Zare R.N.; Gambhir S.S.; Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond)  2011,6(4),715-728","journal-title":"Nanomedicine (Lond)"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","volume":"161","author":"Pasut G.","year":"2012","unstructured":"Pasut G.; Veronese F.M.; State of the art in PEGylation: The great versatility achieved after forty years of research. J Control Release  2012,161(2),461-472","journal-title":"J Control Release"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","volume":"10","author":"Veronese F.M.","year":"2005","unstructured":"Veronese F.M.; Pasut G.; PEGylation, successful approach to drug delivery. Drug Discov Today  2005,10(21),1451-1458","journal-title":"Drug Discov Today"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/acs.biomac.8b01394","volume":"19","author":"Yang H.","year":"2018","unstructured":"Yang H.; Shen W.; Liu W.; Chen L.; Zhang P.; Xiao C.; Chen X.; Pegylated poly(\u03b1-lipoic acid) loaded with doxorubicin as a ph and reduction dual responsive nanomedicine for breast cancer therapy. Biomacromolecules  2018,19(11),4492-4503","journal-title":"Biomacromolecules"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40843-019-1183-0","volume":"63","author":"Liu Z.","year":"2020","unstructured":"Liu Z.; Tang Z.; Zhang D.; Wu J.; Si X.; Shen N.; Chen X.; A novel GSH responsive poly(alpha-lipoic acid) nanocarrier bonding with the honokiol-DMXAA conjugate for combination therapy. Sci China Mater  2020,63(2),307-315","journal-title":"Sci China Mater"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1039\/C9BM00002J","volume":"7","author":"Liu Z.","year":"2019","unstructured":"Liu Z.; Shen N.; Tang Z.; Zhang D.; Ma L.; Yang C.; Chen X.; An eximious and affordable GSH stimulus-responsive poly(\u03b1-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy. Biomater Sci  2019,7(7),2803-2811","journal-title":"Biomater Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJN.S344491","volume":"17","author":"Lin F.","year":"2022","unstructured":"Lin F.; Liu Y.; Luo W.; Liu S.; Wang Y.; Gu R.; Liu W.; Xiao C.; Minocycline-loaded poly(\u03b1-lipoic acid)\u2013methylprednisolone prodrug nanoparticles for the combined anti-inflammatory treatment of spinal cord injury. Int J Nanomedicine  2022,17,91-104","journal-title":"Int J Nanomedicine"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.biomaterials.2009.01.026","volume":"30","author":"Meng F.","year":"2009","unstructured":"Meng F.; Hennink W.E.; Zhong Z.; Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials  2009,30(12),2180-2198","journal-title":"Biomaterials"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1016\/j.bmc.2016.08.070","volume":"24","author":"Jiang F.","year":"2016","unstructured":"Jiang F.; Wang H.J.; Bao Q.C.; Wang L.; Jin Y.H.; Zhang Q.; Jiang D.; You Q.D.; Xu X.L.; Optimization and biological evaluation of celastrol derivatives as Hsp90\u2013Cdc37 interaction disruptors with improved druglike properties. Bioorg Med Chem  2016,24(21),5431-5439","journal-title":"Bioorg Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1002\/pola.24325","volume":"48","author":"Kisanuki A.","year":"2010","unstructured":"Kisanuki A.; Kimpara Y.; Oikado Y.; Kado N.; Matsumoto M.I.T.S.U.A.K.I.; Endo K.; Ring\u2010opening polymerization of lipoic acid and characterization of the polymer. J Polym Sci A Polym Chem  2010,48(22),5247-5253","journal-title":"J Polym Sci A Polym Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.colsurfb.2018.05.025","volume":"169","author":"Li Y.","year":"2018","unstructured":"Li Y.; Yang H.; Yao J.; Yu H.; Chen X.; Zhang P.; Xiao C.; Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy. Colloids Surf B Biointerfaces  2018,169,273-279","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1021\/mp4007387","volume":"11","author":"Lv S.","year":"2014","unstructured":"Lv S.; Song W.; Tang Z.; Li M.; Yu H.; Hong H.; Chen X.; Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery. Mol Pharm  2014,11(5),1562-1574","journal-title":"Mol Pharm"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1021\/acs.est.1c08503","volume":"56","author":"Zhu J.","year":"2022","unstructured":"Zhu J.; Wang J.; Chen R.; Feng Q.; Zhan X.; Cellular process of polystyrene nanoparticles entry into wheat roots. Environ Sci Technol  2022,56(10),6436-6444","journal-title":"Environ Sci Technol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1021\/acs.nanolett.0c02463","volume":"20","author":"Roshanzadeh A.","year":"2020","unstructured":"Roshanzadeh A.; Park S.; Ganjbakhsh S.E.; Park J.; Lee D.H.; Lee S.; Kim E.S.; Surface charge-dependent cytotoxicity of plastic nanoparticles in alveolar cells under cyclic stretches. Nano Lett  2020,20(10),7168-7176","journal-title":"Nano Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1039\/C6QM00135A","volume":"1","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Han L.; Liu M.; Wang K.; Tao L.; Wan Q.; Wei Y.; Recent progress and advances in redox-responsive polymers as controlled delivery nanoplatforms. Mater Chem Front  2017,1(5),807-822","journal-title":"Mater Chem Front"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.mattod.2015.11.025","volume":"19","author":"Mo R.","year":"2016","unstructured":"Mo R.; Gu Z.; Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery. Mater Today  2016,19(5),274-283","journal-title":"Mater Today"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"10673","DOI":"10.1021\/acsami.6b00426","volume":"8","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Ding J.; Li M.; Chen X.; Xiao C.; Zhuang X.; Huang Y.; Chen X.; One-step \u201cclick chemistry\u201d-synthesized cross-linked prodrug nanogel for highly selective intracellular drug delivery and upregulated antitumor efficacy. ACS Appl Mater Interfaces  2016,8(17),10673-10682","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.actbio.2016.04.007","volume":"40","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Xiao C.; Ding J.; Li M.; Chen X.; Tang Z.; Zhuang X.; Chen X.; A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo. Acta Biomater  2016,40,243-253","journal-title":"Acta Biomater"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018298512240819101159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233384\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672018298512240819101159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:49:32Z","timestamp":1770785372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233384\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672018298512240819101159","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}